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A B S T R A C T
Macroalgae or seaweed are relative un-explored and promising sources of novel molecules for the food industry
including peptides and carbohydrates for their use as functional foods and nutraceuticals. Several algae-derived
bioactive compounds have shown a wide range of biological activities both in vitro and in vivo, i.e. anti-
hypertensive and antioxidant, that are strongly associated with the chemical structure of the peptides or car-
bohydrates. Multiple improvements in the purification and analytical tools to characterize these compounds
have been reported in recent years, aiming to gain further insight into the complexity of different molecular
structures of bioactive peptides and carbohydrates. This paper discusses the variable composition of algae and
the opportunities of the use of this biomass to obtain novel functional bioactive peptides and carbohydrates for
functional food applications. The main biological activities of the discovered bioactive peptides and carbohy-
drates together with the analytical procedures used to purify and characterize multiple compounds are also
discussed.
1. Introduction
Traditional food ingredients have gained increased scientific at-
tention for their potential to generate functional foods and nu-
traceuticals. Functional foods are defined as foods that may impart a
health benefit to the consumer that goes above and beyond basic
human nutrition [1]. Several successful examples in the market include
the use of fortified products with omega-3 polyunsaturated fatty acids
of algal origin [1] and beverages containing bioactive peptides such as
Evolus® or Calpis® [2].
Algae are a rich source of multiple valuable macro- and micro-nu-
trients, including proteins, carbohydrates, phenols, vitamins, and mi-
nerals [1,3]. These compounds were traditionally exploited by the food
and animal feed industries due to their nutritional value, i.e. as a source
of proteins rich in essential amino acids [4] or the use of non-digestible
carbohydrates from seaweed as a source of dietary fibre [5]. This rich
and variable composition of algae is being explored for its potential to
obtain functional ingredients including bioactive peptides and carbo-
hydrates [1,5–8]. Bioactive peptides are sequences of 2 to 30 amino
acids in length that display hormone-like beneficial properties when
released from their parent protein [9,10]. Biological effects described to
date include antihypertensive, antioxidant, antithrombotic, anti-
microbial, and immunomodulatory properties [1,5]. Currently there are
a number of products in the market containing bioactive peptides, in-
cluding a peptide soup containing the peptides LKPNM obtained from
dried bonito and a sardine-derived product rich in the di-peptide VY
[1]. Moreover, algal carbohydrates such as alginates or carrageenan are
industrially commercialized as thickening and gelling agents with
multiple applications in the food, textile, biotechnological, and bio-
medical industries [11]. These marine carbohydrates have recently
come under the spotlight as functional food ingredients [5]. Seaweed
carbohydrates such as alginates, carrageenan, and fucoidan showed a
wide range of biological activities including antiinflammatory, antic-
oagulant, antioxidant, antiproliferative, and immunostimulatory activ-
ities both “in vitro” and/or “in vivo” [5]. Furthermore, algal poly-
saccharides such as laminarin are non-digested in the upper
gastrointestinal tract and are considered as dietary fibre [5]. The con-
sumption of dietary fibre has a positive influence on human health with
beneficial impacts including a reduced risk of suffering from colon
cancer and constipation, but also reduced hypercholesterolemia, obe-
sity, and diabetes [12].
The biological effects displayed by these marine bioactive peptides
and carbohydrates depend on the chemical structure of these molecules
[1,13]. These differences could be attributed to biological factors af-
fecting the seaweed biomass (i.e. season and location of collection), but
also to structural modifications of the molecules during the processes of
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extraction and purification [5,14]. The increased interest in developing
functional bioactive peptides and polysaccharides represents a chal-
lenge for analytical scientist trying to identify the relationship between
the chemical structure of these compounds and their biological activ-
ities. Multiple analytical approaches have been used to date to purify
and analyse the chemical structure of bioactive peptides and carbohy-
drates [5,15].
This paper discusses the variable composition of algae and the op-
portunities of the use macroalgae to obtain novel functional bioactive
peptides and carbohydrates for functional food applications. The main
biological activities of the discovered bioactive peptides and carbohy-
drates together with the analytical procedures used to purify and
characterize multiple compounds are also discussed.
2. Chemistry and biochemistry of macroalgae
Macroalgae or seaweed comprise a heterogeneous group of ap-
proximately 10,000 species [16], being only few of them used for food
applications, mainly as food additives or flavouring materials, espe-
cially in Asian countries. Indeed, seaweed is served in approximately
21% of meals in Japan [17] and some eastern varieties are increasingly
consumed in western countries since oriental food became more pop-
ular.
Algae can be divided into three main groups or phyla: brown
(Phaeophyceae), red (Rhodophyceae), and green (Chlorophyceae).
Moisture content of fresh marine algae is very high and can account for
up to 94% of the biomass [18]. In addition, algae have a highly variable
composition, with large differences in their final content in minerals
(including calcium, phosphorus, and potassium), vitamins, proteins,
lipids, and fibre [8]. Seaweed composition, i.e. protein and carbohy-
drate contents, depends not only on the species, but also on the time of
collection and habitat, and on external conditions such as temperature,
light intensity, and nutrient concentration in water [16].
2.1. Protein and amino acid contents in macroalgae
2.1.1. Protein content
As mentioned previously, the protein content of seaweed differs
depending on different factors. In addition, comparison of the protein
content among algae is difficult because of methodological differences,
especially during protein extraction, and the large number of species
identified to date [19]. Although brown seaweed usually contains a low
protein content when compared to that of green or red seaweed,
Lourenço, Barbarino, De-Paula, Pereira and Marquez [19] reported a
relatively high protein content ranging between 10 and 15% for the
species Chnoospora minima, Dictyota menstrualis, Padina gymnospora, and
Sargassum vulgare. Common brown seaweed includes Laminaria digitata,
Ascophyllum nodosum, Fucus vesiculosus, and Himanthalia elongata. The
average protein content of Laminaria digitata was recently calculated as
6.8%, with highest and lowest protein levels in the first and third
quarter of the year, respectively [20]. This value was similar to that
obtained by Peinado, Girón, Koutsidis and Ames [21], who calculated
the protein content of Laminaria digitata as 5.8%. Comparable results
were observed in this study for other brown algae species such as La-
minaria hyperborea, Saccharina latissima, and Alaria esculenta with
average protein levels ranging between 6.8 and 11.0% of the total dry
weight (DW) [20] and Ascophyllum nodosum, Pelvetia canaliculata, Fucus
vesiculosus, and Fucus spiralis which presented an average protein con-
tent of 5.2, 7.3, 5.8, and 5.9%, respectively [21].
Although previous studies highlighted that in some green seaweed,
such as those species belonging to the genus Ulva, the protein content
can range between 10 and 26% of the total DW [22], a more recent
study reported that the protein content of Ulva lactuca, harvested be-
tween May and June, was below 8.6% [23]. Mæhre, Malde, Eilertsen
and Elvevoll [23] obtained similar results from other green algae such
as Cladophora rupestris and Enteromorpha intestinalis, which were also
harvested between May and June in Scotland, and had a total protein
content of 3.4 and 11.3%, respectively. In addition, Lourenço, Bar-
barino, De-Paula, Pereira and Marquez [19] calculated the protein
content of the green algae Caulerpa fastigiata, Caulerpa racemosa, Co-
dium decorticatum, Codium spongiosum, Codium taylorii, and Ulva fas-
ciata, collected in Brazil in autumn, and results suggested that the
protein content varied between 11 and 20%, depending on the species.
Higher protein concentrations were reported in red seaweed, such
as Phorphyra tenera and Palmaria palmata, which can be up to 47% [22].
However, in a more recent study, Mæhre, Malde, Eilertsen and Elvevoll
[23] calculated the protein content of Palmaria palmata and Vertebrata
lanosa, harvested between May and June in Scotland, as 12.2 and
11.5%, respectively. Results correlate well with those obtained by
Galland-Irmouli, Fleurence, Lamghari, Luçon, Rouxel, Barbaroux, Bro-
nowicki, Villaume and Guéant [24], who showed that the protein
content of Palmaria palmata significantly varied depending on the
season, with the highest protein content (21%) at the end of the winter
season and the lowest (11%) in early autumn. The total protein content
of the species Acanthophora spicifera, Aglaothamnion uruguayense,
Cryptonemia seminervis, Gracilariopsis tenuifrons, Laurencia flagellifera,
Plocamium brasiliense, Pterocladiella capillacea, and Porphyria acantho-
phora was determined by Lourenço, Barbarino, De-Paula, Pereira and
Marquez [19], who reported a variable protein content ranging be-
tween 12% (Acanthophora spicifera) and 27% (Aglaothamnion ur-
uguayense) on a DW basis.
Numerous seaweed-derived proteins have been identified, and these
can be used for the generation of biologically active peptides with
health-promoting properties. However, among the different classes of
proteins identified, it is important to emphasize lectins and phycobili-
proteins. Lectins are glycoproteins with carbohydrate-binding proper-
ties which allows them to agglutinate microbes, yeasts, tumour cells,
and erythrocytes [25]. Lectins are very interesting for a diversity of
applications in immunological and histochemical studies [26] as well as
in agricultural and medical applications due to their antimicrobial,
antitumor, and antiviral activities [27]. In addition, phycobiliproteins
are brilliantly coloured and highly fluorescent components which are
currently used in numerous fluorescence-based techniques such as im-
munofluorescence, fluorescence-activated cell sorting, and fluorimetric
microplate assays [28].
2.1.2. Amino acid composition
The amino acid composition of seaweed proteins has been re-
peatedly studied and compared to that of other foods. Most seaweed
contain all the essential amino acids, and aspartic and glutamic acids
were suggested to constitute a large part of their amino acid fraction
[22]. Indeed, these two residues represent 22 and 44% of the total
amino acids in certain brown seaweed [29]. Brown seaweed have been
suggested as rich sources of threonine, valine, leucine, lysine, glycine,
and alanine previously, and amino acids such as cysteine, methionine,
histidine, tryptophan, and tyrosine were recorded at lower levels [18].
Lourenço, Barbarino, De-Paula, Pereira and Marquez [19] studied the
amino acid profile of four brown seaweed species namely Chnoospora
minima, Dictyota menstrualis, Padina gymnospora, and Sargassum vulgare.
All samples were collected in Brazil in June and September, and showed
a high content of aspartic and glutamic acid, and a relatively high (over
8%) content of leucine.
The green seaweed Ulva pertusa contains high levels of proline [30],
and the amino acid profile of the green seaweed Ulva lactuca revealed
that this specie contained all the essential amino acids, in levels which
were comparable to the dietary recommendations proposed by the Food
and Agriculture Organisation of the United Nations (FAO) and the
World Health Organisation (WHO) [31]. Lourenço, Barbarino, De-
Paula, Pereira and Marquez [19] reported high concentrations of as-
partic and glutamic acids in six species of green algae, namely Caulerpa
fastigiata, Caulerpa racemosa, Codium decorticatum, Codium spongiosum,
Codium taylorii, and Ulva fasciata. The authors also recorded a relatively
T. Lafarga, et al. Algal Research 48 (2020) 101909
2
high content of the residues leucine and alanine for all the studied
species. In addition, leucine, threonine, isoleucine, valine, and me-
thionine are well represented in the essential amino acid fraction of
Palmaria palmata, with similar leucine and valine concentrations to
those generally reported for ovalbumin, and similar isoleucine and
threonine contents to those recorded for leguminous proteins [22].
The amino acid profile of the red seaweed Hypnea charoides and
Hypnea japonica revealed that both species contained all the essential
amino acids (excluding tryptophan), which accounted for approxi-
mately 42–48% of the total amino acid content [31]. Red seaweed
proteins also contain high quantities of glutamic and aspartic acid.
However, previous studies suggested that the quantities of glutamic and
aspartic acid in red seaweed were significantly lower than those ob-
served in brown and green seaweed [32]. Lourenço, Barbarino, De-
Paula, Pereira and Marquez [19] reported a concentration of aspartic
and glutamic acid ranging between 10 and 15% in numerous red algae
species including Acanthophora spicifera, Aglaothamnion uruguayense,
Cryptonemia seminervis, Gracilariopsis tenuifrons, Laurencia flagellifera,
and Porphyria acanthophora. Relatively high concentrations (over 7%)
of leucine, valine, and glycine were recorded for the red seaweed Por-
phyria tenra [30], and concentrations of approximately 10% of alanine,
threonine, proline, and histidine were reported for Acanthophora delillii
[33]. Similar results were obtained for the red algae Hypnea muciformis,
Sebdania polydactlyla, and Scinia indica, which had an approximate
proline concentration of 10% [33].
Overall, glutamic and aspartic acid were the most abundant amino
acids in most species. Methionine content was reported to be low in
most of the species, and the mean values for individual amino acids
were, in the majority of the reviewed studies, similar in brown, green,
and red algae.
2.2. Carbohydrate contents in macroalgae
Seaweed also contain large amounts of polysaccharides with im-
portant functions for the macroalgal cells including structural and en-
ergy storage [5]. The total polysaccharide concentrations in macroalgae
ranged from 4 to 76% of DW with the highest contents described in
Ascophyllum, Porphyra and Palmaria; although other green species such
as Ulva showed contents of up to 65% on a DW basis [18]. Seaweed
polysaccharides include relevant bioactive compounds such as alginate,
carrageenan, fucoidan, and laminarin. Furthermore other phycocolloids
from macroalgae, i.e. agar, are commonly used in the food and animal
feed industries as stabilisers, thickeners, and emulsifiers [13,18].
Alginates are linear unbranched polysaccharides containing β-D-
mannuronic acid (M) and α-L-guluronic acid (G) units linked by 1–4
glycosidic bonds [35]. These monomers are mainly arranged in se-
quences of homopolymeric blocks (MM and GG blocks) and hetero-
polymeric blocks (MG or GM blocks) [34]. Alginates are currently
produced from brown seaweed of the genus Laminaria, Saccharina,
Lessonia, Macrocystis, Durvillaea, Ecklonia, and Ascophyllum [34], being
Durvillaea potatorum and Macrocystis pyrifera the species with the
highest yields of alginates of up to 55 and 45% of DW, respectively
[35,36].
Carrageenans (CRGs) are sulphated linear galactans, consisting of
alternating β-1,4- and α-1,3-linked D-galactosyl residues (D- and G-
units). Carrageenans are characterized depending on the disaccharide
repeating unit and the degree of sulphation of the molecule [37]. The
three most industrially exploited types, namely Kappa, Iota, and
Lambda are distinguished by the presence of one, two, and three ester-
sulphate groups per repeating disaccharide unit respectively. However,
the sulphate contents of the commercial carrageenans can vary de-
pending on the seaweed specie or batch [38]. Chondrus crispus and
Kappaphycus sp. contain up to 71 and 88% of carrageenan, respectively
[18].
Fucoidans are cell wall polysaccharides present in brown macro-
algae which play a crucial role in the protection of macroalgae against
environmental challenges [5]. Fucoidans are fucose containing sulph-
ated polysaccharides formed of a backbone of (1 → 3)-linked α-L-fu-
copyranosyl or alternating (1 → 3)- and (1 → 4)-linked α-L-fucopyr-
anosyl residues with variable degrees of sulphation [5]. These
polysaccharides are a chemically diverse group with molecular weights
ranging from 43 to 1600 kDa [39]. The content and composition of
fucoidan varies depending on the season and seaweed specie [5]. Fucus
vesiculosus had fucoidan levels ranging from 16 to 20%, while Undaria
pinnatifida contained approximately 1.5% [18]. Furthermore, recent
studies also showed differences in the fucoidan content depending on
the stage of growth of the seaweed. Cultured Laminaria japonica showed
the highest contents of fucoidan in October, when the seaweed blades
were matured rather than at younger stages of development [40].
Laminarins are a group of energy storage polysaccharides composed
by 1,3-linked β-D-glucose monosaccharides with variable branching at
β-(1,6) [5]. The laminarin structure may vary in the degree of
branching and degree of polymerization depending on the seaweed
specie, season, and other parameters such as extraction and purification
procedures [5]. Laminarin is present in high yields in Laminaria sp. (up
to 32%, depending on the season) and Saccharina sp., but these mole-
cules have been also described in Ascophyllum, Fucus, and Undaria sp.
[18]. Seasonal studies on Laminaria sp. showed higher accumulation of
storage carbohydrates during summer and autumn that will be used
during the winter as an energy source for new tissue growth [21].
3. Seaweed-derived bioactive compounds
3.1. Bioactive peptides derived from edible seaweed
As mentioned previously, algae are known to contain high con-
centrations of high quality polysaccharides, minerals, and vitamins, as
well as bioactive compounds including proteins, lipids, and numerous
polyphenols [18]. Bioactive peptides have been generated from a wide
variety of natural sources including meat [10,41,42], milk [43,44],
cereals [45,46], and fish [47,48]. Although there has been a growing
demand to isolate bioactive peptides from marine algae [9,49], the
number of biologically active peptides generated from seaweed is still
limited. A number of functional foods containing seaweed-derived
peptides are currently commercialized, mainly in Japan. The Japanese
Ministry of Health and Welfare established a policy for approving some
selected functional food products as Foods for Specified Health Uses
(FOSHU) whose health claims are legally permitted [50]. Seaweed-
derived peptide-containing products with FOSHU approved anti-
hypertensive claims include Wakame peptide jelly (Riken Vitamin Co.,
Ltd., Tokyo, Japan) and Nori peptide S (Shirako Co., Ltd., Tokyo,
Japan) [51].
3.1.1. Antioxidant peptides
A free radical can be defined as a chemical substance capable of
independent existence with one or more unpaired orbital electrons, and
can be produced either from normal cell metabolism in situ of from
external sources such as radiation or pollution [52]. When free radicals
are produces in excess, and cannot gradually be destroyed, their accu-
mulation in the body generates a phenomenon called oxidative stress
[52]. The regulation of oxidative stress is an important factor in both,
tumour development and responses to anticancer therapies [53]. An-
tioxidants can counteract oxidative stress, and these are either pro-
duced by the human body in situ or incorporate through diet.
Seaweed are a rich source of antioxidants. For example, the known
antioxidant peptides carnosine and glutathione, which are generally
present in animal muscle, were identified in seaweed species previously
[54]. In addition, as mentioned previously, seaweed can contain rela-
tively high protein content, and seaweed-derived proteins can be used
for the generation of antioxidant hydrolysates and peptides. For ex-
ample, Heo, Park, Lee and Jeon [55] generated a large amount of an-
tioxidant hydrolysates of proteins isolated from Ecklonia cava, Ishige
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okamurae, Sargassum fullvelum, Sargassum horneri, Sargassum coreanum,
Sargassum thunbergii, and Scytosipon lomentaria using the commercial
enzymes Alcalase, Flavourzyme, Neutrase, Protamex, and Kojizyme. In
this study, antioxidant activity was assessed using four different anti-
oxidant scavenging assays and results demonstrated that the anti-
oxidant potential of the Alcalase hydrolysates of Sargassum horneri were
dose-dependent and thermally stable. In a more recent study, Cian,
Martínez-Augustin and Drago [56] obtained different enzymatic hy-
drolysates from co-products of Porphyra columbina using alcalase,
trypsin, and combinations of both. In addition, Harnedy, O'Keeffe, and
FitzGerald (2017) generated an enzymatic hydrolysate of Palmaria
palmata using the food-grade enzyme Corolase PP. The generated hy-
drolysate was sequentially fractionated using solid phase extraction and
semi-preparative reversed-phase high performance chromatography
(RP-HPLC) and the peptide SDITRPGNM showed the highest oxygen
radical absorbance capacity (ORAC) and ferric reducing antioxidant
power (FRAP) activity with values of 152.43 ± 2.73 and
21.23 ± 0.90 nmol TE/μmol peptide, respectively. Bioavailability of
peptides with antioxidant properties has been also evaluated. Indeed,
Cian, Garzón, Ancona, Guerrero and Drago [57] observed that anti-
oxidant activity of peptides derived from Pyropia columbina increased
after a simulated gastrointestinal digestion.
3.1.2. Bioactive peptides and their role in diseases related to metabolic
syndrome
The term metabolic syndrome describes a combination of medical
disorders which increase the risk of developing cardiovascular disease,
and these include obesity, diabetes, hypertension, lipid disorders, and
alterations in the thrombotic potential [58]. Some of these disorders
can be prevented or controlled by the inhibition of a number of en-
zymes and regulation systems by the use of chemically synthesised
drugs or the ingestion of nutraceuticals or functional foods.
Venous thromboembolism (VTE) is a common and underestimated
condition and one of the main causes of death and disability in high-
income countries [59]. Blood coagulation is a complex mechanism with
numerous coagulation factors and enzymes involved, and because of
this, thrombus formation can be inhibited using different mechanisms
[60]. The role of anticoagulants such as aspirin in the primary pre-
vention of VTE has been evaluated in various clinical studies that as-
sociated this drug with a reduction of up to 50% in the risk to suffer
VTE [61]. However, treatment with aspirin was also associated with an
increased risk of bleeding. For this reason, investigations into the
identification of novel antithrombotic compounds from different
sources, including seaweed, are on-going. Antithrombotic peptides have
been previously generated from milk proteins [60]. Up to the best of
our knowledge, the peptide NMEKGSSSVVSSRMKQ, recently reported
by Indumathi and Mehta [62], was the first antithrombotic peptide
generated from seaweed. This peptide was generated by hydrolysis of
Porphyra yezoensis proteins using pepsin. In vitro anticoagulation results
showed a dose-dependent prolongation of activated partial thrombo-
plastin time, a medical test that characterises blood coagulation, and
the authors suggested that the peptide interacted with the clotting
factors involved in the intrinsic pathway of coagulation. In addition,
Indumathi and Mehta [62] recently isolated the anticoagulant peptide
NMEKGSSSVVSSRM(+15.99)KQ from a Nori hydrolysate. Antic-
oagulation was measured by microtiter plate reader and was found to
be non-cytotoxic and to have a similar order of activity as that of he-
parin.
Seaweed-derived bioactive peptides identified to date also include
enzymatic inhibitors of the enzymes renin (EC 3.4.23.15) and angio-
tensin-I-converting enzyme (ACEeI; EC 3.4.15.1). Inhibition of renin,
ACEeI, and other enzymes involved in the renin-angiotensin-aldos-
terone system (RAAS) plays a key role in the treatment of hypertension
[63]. These enzymes can be inhibited by the use of chemically syn-
thesised drugs or the ingestion of functional foods. There are a number
of bioactive peptide-containing functional foods which are
commercially available worldwide. For example, the Japanese com-
pany Senmi Ekisu Co. Ltd. obtained generally recognized as safe (GRAS)
status for its hydrolysed sardine muscle protein from the Food and Drug
Administration (FDA) of the United States (US). This product, labelled
as Valtyron®, is rich in the di-peptide VY with known ACE-I inhibitory
and antihypertensive benefits [64]. In addition, the European Food
Safety Authority (EFSA) issued a positive opinion regarding the safety
of hydrolysed sardine muscle protein, for use as a novel food ingredient
in 2010 [7]. Bioactive algae-derived hydrolysates and peptides with in
vitro ACE-I inhibitory activity include enzymatic hydrolysates of Spir-
ulina platensis (cyanobacteria) and Polysiphonia urceolata, which in-
hibited the activity of ACE-I by half at concentrations ranging between
0.1 and 1.0, depending on the enzymatic treatment [49], and the tetra-
peptides AIYK, YKYY, KFYG, and YNKL, which were identified from a
peptic digest of Undaria pinnatifida and showed ACE-I IC50 values of
213, 64, 90, and 21 μM, respectively [65]. In addition, Qu, Ma, Pan,
Luo, Wang and He [66] generated several enzymatic hydrolysates of
Porphyra yezoensis using commercially available enzymes and suggested
papain, protamex, alcalase, and neutrase as the most efficient enzymes,
from those studied, for the generation of ACE-I inhibitory peptides from
Porphyra yezoensis. The ACE-I inhibitory activity of the alcalase hy-
drolysates, generated following these methods, was stable after storage
at temperatures ranging between 4 and 37 °C. As mentioned previously,
inhibition of enzymes involved in the RAAS, such as renin, also plays a
key role in the treatment of hypertension. Indeed, renin regulates the
initial, rate-limiting step of the RAAS and inhibition of renin has long
been considered the logical therapeutic target for blocking the system
[67]. Only few renin inhibitory peptides have been reported to date,
and these were mainly generated from pea [68] and blood [15,69]
proteins. However, Fitzgerald, Aluko, Hossain, Rai and Hayes [7] re-
cently reported the renin inhibitory peptide IRLIIVLMPILMA, which
showed an in vitro renin IC50 value of 3.34 mM, and was identified from
a papain hydrolysate of Palmaria palmata. Up to the best of our
knowledge, this is the only seaweed-derived renin inhibitory peptide
identified to date. The peptide IRLIIVLMPILMA and the papain hydro-
lysate from where it was identified not only inhibited renin in vitro, but
also showed in vivo antihypertensive activities after oral administration
in spontaneously hypertensive rats (SHRs) at a dosage of 50 mg/kg
body weight [7].
Moreover, seaweed-derived peptides have been also shown to be
efficient inhibiting the enzymes dipeptidyl peptidase-IV (DPP-IV; EC
3.4.14.5) and platelet-activating factor acetylhydrolase (PAF-AH; EC
3.1.1.47). DPP-IV degrades and inactivates glucagon-like peptide-1
(GLP-1) and gastric-inhibitory peptide (GIP), two incretin hormones
which contribute to the enhancement of glucose-induced insulin se-
cretion [70]. In addition, PAF-AH is thought to be involved in the
generation of lysophosphatidylcholine (LPC) and oxidized non-ester-
ified fatty acids (NEFA), pro-inflammatory mediators which lead to the
recruitment and activation of leukocytes and induce apoptosis and
impaired removal of dead cells [71]. Inflammation has been also linked
to obesity, hypertension, and other disorders related to metabolic
syndrome previously [72]. Seaweed-derived DPP-IV inhibitory peptides
identified to date include the peptides ILAP, LLAP, and MAGVDHI,
recently reported by Harnedy, O'Keeffe and FitzGerald [73]. The pep-
tides ILAP, LLAP, and MAGVDHI were generated from an aqueous
protein extract of Palmaria palmata using Corolase PP and showed DPP-
IV IC50 values of 43.4, 53.7, and 159.4 μM, respectively. In addition,
Fitzgerald, Gallagher, O'Connor, Prieto, Mora-Soler, Grealy and Hayes
[74] identified the PAF-AH inhibitory tetra-peptide NIGK, which was
generated from Palmaria palmata using papain and showed a PAF-AH
IC50 value of 2.3 mM.
3.2. Seaweed-derived bioactive carbohydrates
Macroalgal carbohydrates display a wide range of biological prop-
erties including antiinflammatory, immunostimulatory, antioxidant,
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anticoagulant, antiviral, antiproliferative, and antitumour properties
[5,13]. These biological activities could be attributed to the high con-
tent of sulphated polysaccharides of seaweed (i.e. carrageenans, and
fucoidan), which cannot be found in terrestrial plants [13]. Further-
more, seaweed polysaccharides such as alginates, fucoidan, and lami-
narin, are non-digested in the upper digestive track of the animals,
being macroalgae considered as a rich source of dietary fibre [5,13].
Despite these beneficial properties, seaweed carbohydrates are being
currently exploited industrially for their physicochemical properties,
i.e. the ability of alginates and carrageenans to form gels, allowing their
use as thickening, gelling, and protein-suspending agents [13,38].
Alginates from brown macroalgae showed a wide potential for its
application in the biomedical and bioengineering fields, due to its
gelling capacity, biocompatibility, biodegradability and lack of toxicity
[75]. Nutritionally, alginates are dietary fibres and contribute to the
gut's health due to its water binding properties and thus its effects in
faecal bulking, decreasing the colonic transit times which could be
beneficial in preventing colonic cancer [76]. Furthermore, the Food and
Drug Administration (FDA) named alginic acid and its salts as generally
regarded as safe (GRAS) ingredients for oral administration [75].
Other macroalgal polysaccharides such as laminarin and fucoidan
are also considered as dietary fibres [5]. Laminarin modulates the in-
testinal metabolism by affecting the biochemical and microbiology of
the human gut microflora [77]. In vivo studies showed a down-regula-
tion of pro- and antiinflammatory cytokines in post-weaning pigs sup-
plemented with laminarin [78]. Laminarin and fucoidan supplementa-
tion to sows during the periods of pregnancy and lactation showed an
increase on immunoglobulin concentrations in the colostrum and a
decrease of E. coli in suckling [79] and weaned piglets [80].
Further biological properties described for fucoidan with potential
biomedical applications include the antioxidant and antiinflammatory
activities, anticancer, anticoagulant and antithrombotic activities re-
lated to the structure and the degree of sulphation of the polysaccharide
[81,82]. Fucoidan from Fucus evanescens showed anticoagulant activ-
ities similar to other drugs such as heparin in vitro and in vivo [83].
Other sulphated polysaccharides such as carrageenans have also
gathered scientific attention due to its biological properties including
anti-inflammatory and immunomodulatory, but also antitumor, anti-
hyperlipidemic, antiviral and anticoagulant properties using different in
vitro and in vivo models [38]. Carrageenan gels from Chondrus crispus
had antiviral properties against HIV virus and other sexual transmitted
diseases such as herpes simplex virus [38]. As in the case of fucoidan,
the main explanation for the anticoagulant activities of carrageenan
appeared to be related with the degree of sulphation of the molecules
with λ-carrageenan showing the highest antithrombotic activities fol-
lowed by κ-carrageenan [18].
4. Analysis of bioactive peptides and carbohydrates
4.1. Purification of bioactive peptides and carbohydrates
For the determination of the sequence of a peptide and to perform
individual activity assays, an effective purification of the target specie is
necessary. Purification of peptides and obtaining them in sufficient
quantities is a complex and expensive process. Ultrafiltration mem-
brane systems are fast and economic devices that are used to separate
peptides with the desired MW by choosing the correct molecular weight
cut-off (MWCO). Several studies enriched enzymatic hydrolysates and
peptides derived from not only seaweed but other food sources using
MWCO membranes. For example, Bondu, Bonnet, Gaubert, Deslandes,
Turgeon and Beaulieu [84] utilized 1 and 10 kDa MWCO membranes
for the purification of proteins and peptides derived from several
macroalgae varieties including Ulva lactuca, Solieria chordalis, Palmaria
palmata, and Saccharina longicruris. A similar strategy was followed by
Beaulieu, Sirois and Tamigneaux [85] to purify peptides from Palmaria
palmata. However, membranes have been reported to be poorly
reproducible and could remove peptides below the desired MW [86].
Interactions between the peptide and the membrane can occur. The
most hydrophobic peptides can adsorb on the membrane and be de-
pleted from the sample [87]. Therefore, the separation and purification
of not only peptides but also polysaccharides from seaweed for later
identification is commonly achieved using one or multiple chromato-
graphic techniques which have the advantage that can be used for
qualitative and quantitative analysis as well as for preparative pur-
poses.
Liquid chromatography (LC) has also been used extensively for the
purification of bioactive peptides include mainly RP-HPLC, using col-
umns packed with silica particles modified with C-18 chains
[9,54,73,74,88]. Several lengths (50–400 mm), inner diameters
(1.4–2.6 mm), and particle sizes (1.7–5.0 μm) were utilized in order to
achieve a suitable resolution between the target compounds. In addi-
tion, in relation to mobile phases used, mixtures of formic acid in water
and formic acid in acetonitrile are the most commonly used (Table 1).
UPLC applies the principles of separation of HPLC. UPLC uses low
particle size columns (less than 2 μm in diameter) and UPLC in-
strumentation (solvent and sample manager units) to operate at higher
pressures, increasing the resolution, sensitivity, and speed of the ana-
lysis [89]. UPLC has been used recently not only for the purification of
bioactive compounds but also to characterize the amino acid compo-
sition of 21 seaweed species from Norway [90]. LC is not regularly used
for the purification of polar compounds such as carbohydrates. How-
ever, this separation technique could be used to analyse the mono-
saccharide composition of carbohydrates. Recently Liu, Wang, Song,
He, Ren, Cong and Wu [91] analysed the monosaccharide composition
of fucoidan extracts using a C-18 column (ZORBAX Eclipse XDB, 5 μm,
4.6 mm × 250 mm) following the acidic hydrolysis and derivatization
of the compounds using 1-phenyl-3-methyl-5-pyrazolone (PMP) for its
detection with UV at 250 nm. UPLC systems were also used to purify ad
characterize multiple carbohydrates in products of plant [92,93] and
animal origin [94]. Recently, Adrien, Dufour, Baudouin, Maugard and
Bridiau [96] used UPLC coupled with MS to analyse the mono-
saccharide composition of seaweed extracts from Himanthalia elongata,
Laminaria digitata, Ascophyllum nodosum, Fucus vesiculosus, Ulva lactuca,
and Chondrus crispus with anticoagulant properties.
Nevertheless, the direct application of one LC method does not
allow the detection of the investigated compounds, especially if they
are present in the mixture in low quantities. Therefore, multi-
dimensional approaches are generally used. Ion exchange chromato-
graphy (IEC) is one of the classic methods among multidimensional
approaches. IEC achieves the separation of peptides and carbohydrates
based on the adsorption of the charged analytes on to immobilized ion
exchange groups of an opposite charge in the stationary phase of the
column and its elution by changing the concentration or pH of the
mobile phase [5]. Carbohydrates from seaweed are normally separated
using IEC containing positively charged resins as stationary phase with
affinity for negatively charged analytes (anion-exchange chromato-
graphy (AEC)). AEC is one of the most commonly used purification
techniques used to separate alginates and sulphated polysaccharides
such as fucoidan [5] and carrageenan [38]. The sulphate ester groups
linked to the backbone of these seaweed polysaccharides exhibit high
anionic charges, which facilitate the use of AEC following different
experimental conditions described in detail in Table 2. The elution of
the adsorbed carbohydrates from different resins was performed mainly
by stepwise [97] or linear gradient [98–100] of NaCl or NaOH to
achieved multiple polysaccharide fractions. In addition, IEC purifica-
tion of fucoidan extracts followed by ESI-MS analysis was used to de-
termine the monosaccharide composition of the different fucoidan
fractions obtained from Sargassum fusiforme [97], while IEC followed by
ESI-MS/MS was used to characterize fucoidan carbohydrates with an-
ticancer activity from Padina boryana [101]. ESI-MS/MS was used to
characterize the monosaccharide units of immunomodulatory and anti-
HIV fucoidan fractions from Sargassum mcclurei, Sargassum polycystum
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and Turbinara ornate [102] and from Sargassum crassifolium and Padina
australis [103], respectively.
SEC is also a common stem in multidimensional fractionation of
bioactive peptides. Today, SEC is the most widely accepted and used
analytical method for the measurement of MW distributions of biopo-
lymers [104]. Briefly, SEC is a liquid chromatographic technique in
which a sample solution is introduced into a column filled with porous
packing, often silica-based, carried through the column by a solvent,
and separated by differential pore permeation [104]. Unlike IEC,
polymers do not bind to the inert material of the columns and thus the
composition of the buffer has no effect on the separation of the com-
pounds, enabling to use the type of solvent that better suits the pre-
servation of the compounds of interest for further use or purification
and chemical characterization [5]. SEC can provide a rapid estimate of
the MW of a peptide, obtained under denaturing conditions, when all
polypeptides have the same random coil structure [105]. Small peptides
with just a few amino acid residues in length do not usually adopt stable
structures in solution. However, in rare occasions small peptides were
shown to form stable secondary structures. For example, the fragment
Aβ (25–35) of the Alzheimer β-amyloid peptide was demonstrated to
undergo from a random coil to a β-sheet structure previously [106].
Peptide bonds absorb UV light with a maximum around 187 nm.
However, because of interference from buffer components, wavelengths
ranging between 210 and 220 nm are the most frequently used [105].
SEC has been used for the determination of the MW distributions of
multiple seaweed carbohydrates as seen in Table 2. The separation of
different MW alginates and fucoidans was achieved by the use of a
single column or various columns connected successively, being the
elution of the different compounds monitored by refractive index de-
tector (RI) [97,100,101,107] or evaporative light-scattering detector
(ELSD) [108]. Both IR and ELSD are commonly used to detect com-
pounds that cannot be efficiently detected with UV spectra. Recent
innovations in the purification of carbohydrates include the separation
of polysaccharides such as dextran, fucoidan, alginic acid, and lami-
narin using ionic liquid-modified silica rather than the conventional
SEC silica [109].
4.2. Sequence validation
The identification of the sequence responsible of the observed
bioactivities has been largely neglected or was performed to identify
the most probable sequence. Edman degradation was the first approach
used for peptide identification [87]. However, due to their accuracy and
sensitivity, chromatographic techniques, especially LC-MS/MS methods
have become more popular over the last decade and are considered as a
reference for bioactive compound analysis (Table 1). Other technolo-
gies such as nuclear magnetic resonance (NMR) have been also studied.
MS is an analytical technique that can provide useful data on the
structure and concentration of the analytes of interest in a sample after
their conversion to ions [103]. In MS the analytes are ionised using
high-energy electrons, causing a molecular fragmentation of the ana-
lytes that pass through a mass-to-charge analyser and are detected as a
function of mass-to-time or mass-to-charge ratio (m/z) [110]. In the last
decade, MS has become increasingly important for analysis of peptides
and carbohydrates due to its high sensitivity, accuracy, and fast pro-
cessing times compared to NMR and other detectors [38]. MS techni-
ques commonly used to analyse macroalgal peptides and carbohydrates
include electrospray ionization (ESI) and matrix-assisted laser deso-
rption/ionization (MALDI) which differ on the strategy followed to
ionize the analytes. ESI uses electrical energy to transfer ions from an
initial solution into a gas stage prior to its detection with MS. This io-
nization into gas requires the dispersion of charged droplets, followed
by the evaporation of the solvent and ejection of ions from the highly
charged droplets [111]. ESI-MS is a sensitive, robust and reliable
method capable to detect femtomole quantities of multiple compounds,
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with LC for molecular fractionation prior to MS analysis (LC/ESI-MS) or
to MS in tandem (LC/ESI-MS/MS) are powerful methods recently used
to analyse peptides and carbohydrates in a complex biological samples,
including seaweed extracts [97,101]. The conversion of the analytes to
a gaseous phase performed during ESI could be difficult to achieve
when analysing complex proteins and carbohydrates due to their high
polarity and mass [106]. In MALDI, the analytes are normally mixed
with a matrix to form a solid-state mixture that will be later irradiated
with UV laser pulses (337–355 nm), generating ions analysed based on
its mass-to-charge ratio by MS. Choosing the appropriate matrix for an
analyte is crucial for successful MALDI analysis [112,113].
MALDI continues to be a major technique for the analysis of car-
bohydrates [112]. MALDI-TOF mass spectra was used to analyse the
structure of antiinflammatory κ/β-carrageenans from red algae Ticho-
carpus crinitus [114]. Furthermore, MALDI was recently used to analyse
fucoidan fractions with multiple biological properties from seaweed,
including Saccharina cichorioides [115], Saccharina gurjanovae [116],
Sargassum muticum [117] and Alaria angusta [118].
NMR spectroscopy is one of the most powerful analytical tools
available to date to determine the structure of bioactive compounds
[38,119,120]. NMR is based on the principle of nuclear spin or the fact
that when a molecule is placed in a magnetic field, this momentum will
be aligned either in the same or opposite direction to the field, resulting
in 2 states separated by an energy gap and thus, in resonance frequency
[119]. This difference in resonance frequency will depend on the che-
mical environment of the nucleus in a molecule and on the magnetic
field strength in an effect known as chemical shift [119]. Most elements
have at least one naturally occurring NMR active isotope with variable
frequency of occurrence i.e. the natural abundance of 1H is almost
100% being easier to detect by NMR compared to 13C and 15N isotopes
that appeared naturally in 1.1 and 0.4% respectively [119]. For char-
acterization of carbohydrates, the resonances of 1H NMR in the
anomeric region (4.4–5.5 ppm) and the 13C NMR spectra (95–110 ppm)
provide useful information on the number of monosaccharide units of
the carbohydrates [119]. 1H NMR resonances bellow 1 ppm indicate the
presence of CH3-groups and above 2 ppm reveal N-acetyl and/or O-
acetyl groups [119]. NMR have been used extensively to characterize
the structure of seaweed carbohydrates. Carrageenan can be qualita-
tively and quantitatively characterized by NMR techniques, allowing
the determination of molar rations and the presence monosaccharides
present in the extracts. Both 1H and 13C NMR spectroscopy are ap-
plicable for these purposes, but 1H NMR has the advantage of a rela-
tively high sensitivity and lower time of analysis [38,119]. 1H NMR was
also used to identify and characterize the structural units of alginates
(MM, GG, MG or GM blocks) from multiple seaweed species [34,100].
1H NMR and 13C NMR spectra together with 2D NMR was also used to
characterize a fucoidan fraction with antiangiogenic activity from
macroalgae Sargassum fusiforme [97]. 13C NMR analysis was also per-
formed to characterize fucoidan fractions with hepatoprotective activ-
ities from Kjellmaniella crassifolia [91]. NMR spectra using 1H and 13C
among other techniques were also used by Youssouf, Lallemand,
Giraud, Soulé, Bhaw-Luximon, Meilhac, D'Hellencourt, Jhurry and
Couprie [121] alginates extracted from Sargassum binderi and Turbinaria
ornata and carrageenans from the red macroalgae Kappaphycus alvarezii
and Euchema denticulatum. NMR was recently used for the character-
ization of a glycoprotein with 36.24% carbohydrate, composed of
rhamnose, galactose, glucose, and mannose with a mole ratio of
38:30:26:6 [122]. NMR spectra proved that the above mentioned gly-
coprotein, isolated from the green seaweed Codium decorticum, con-
tained protein and carbohydrate portions with (1 → 4)-linked β-ga-
lactose residues and β-linked glucose residues. Senthilkumar and
Jayanthi [122] demonstrated the anticancer properties of this com-
pound by different cell lines.
5. Conclusions
Seaweed are relative un-explored and promising of novel molecules
for its use as functional foods and nutraceuticals including bioactive
peptides and carbohydrates. Several seaweed derived bioactive com-
pounds have shown a wide range of biological activities both in vitro
and in vivo. Among the biological activities reported by bioactive pep-
tides and polysaccharides the most promising include antihypertensive,
antioxidant, anticoagulant, antitumour, anti-inflammatory, and im-
munostimulatory activities. These biological activities have increased
the scientific interest in developing functional ingredients and to study
the relationship between the chemical structure of the compounds and
the biological activities. Multiple analytical approaches have been used
to date to purify and analyse the chemical structure of bioactive pep-
tides and carbohydrates. Recent improvements in the purification and
characterization methodologies gradually increased the use of novel
chromatographic techniques i.e. ultra-performance liquid chromato-
graphy (UPLC) and analytical techniques such as NMR spectroscopy (1H
and 13C NMR) for qualitative and quantitative analysis and mass
spectrometry (ESI and MALDI) to gain further insight into the com-
plexity of different molecular structures of bioactive peptides and car-
bohydrates.
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